Paper Details

  1. Home
  2. Paper Details

Modeling pharmacokinetics/pharmacodynamics of abatacept and disease progression in collagen-induced arthritic rats: a population approach.

Author: AlmonRichard R, DuBoisDebra C, JuskoWilliam J, LiuDongyang, LonHoi-Kei

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

The study investigated the pharmacokinetics (PK) and pharmacodynamics (PD) of abatacept, a selective T cell co-stimulation modulator, in rats with collagen-induced arthritis (CIA). Abatacept showed modest effects on paw swelling, a measure of disease progression. The PK/PD profiles were well-described by a two-compartment model with linear elimination for abatacept and an indirect response model for disease progression. The study highlights the potential for abatacept to manage CIA in rats and emphasizes the importance of understanding inter-individual variability in PK and PD parameters.
Paper Details　
Original Abstract of the Article :
The PK/PD of abatacept, a selective T cell co-stimulation modulator, was examined in rats with collagen-induced arthritis (CIA) using a nonlinear mixed effect modeling approach. Male Lewis rats underwent collagen induction to produce rheumatoid arthritis. Two single-dose groups received either 10 mg...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/24233383

データ提供：米国国立医学図書館（NLM）

Modeling Abatacept's Pharmacokinetics and Pharmacodynamics in Collagen-Induced Arthritis: Exploring the Desert of Rheumatoid Arthritis

The field of rheumatoid arthritis (RA) research is a vast and complex desert, where researchers strive to understand the intricate mechanisms underlying this autoimmune disease and to develop effective treatments. This study focuses on abatacept, a promising therapeutic agent for RA, investigating its pharmacokinetics (PK) and pharmacodynamics (PD) in a rat model of collagen-induced arthritis (CIA). The researchers employed a population approach to model the PK/PD of abatacept, providing valuable insights into its therapeutic efficacy in a preclinical setting.

Unraveling the Mysteries of Abatacept's Action

The study successfully modeled the PK/PD of abatacept in CIA rats, revealing that the drug exhibits a modest effect on paw swelling. The researchers identified key parameters influencing abatacept's PK and PD, including clearance, central compartment volume, and paw edema production and loss rates. These findings provide a deeper understanding of abatacept's action, paving the way for further optimization of the drug's therapeutic potential.

Navigating the Desert of Rheumatoid Arthritis Treatment

This research offers valuable insights into the PK/PD of abatacept in a preclinical model of RA. The study's findings contribute to our understanding of the drug's efficacy and provide a foundation for further research into its therapeutic potential. As researchers continue to explore the vast desert of RA treatment, this study serves as a valuable stepping stone toward developing more effective and targeted therapies.

Dr. Camel's Conclusion

This study provides valuable insights into the PK/PD of abatacept in a preclinical model of RA, offering a deeper understanding of its therapeutic action. The study's findings contribute to the ongoing quest for effective and targeted treatments for this debilitating disease. As we journey through the vast desert of RA research, this study serves as a reminder that even small steps can lead to significant breakthroughs in our understanding of this complex condition.

Date :
  1. Date Completed 2014-07-07
  2. Date Revised 2021-10-21
Further Info :

Pubmed ID

24233383

DOI: Digital Object Identifier

NIHMS540390

Related Literature

Article Analysis
・Effects of abatacept injection
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.